What are the Implications of Incomplete Data on Regulatory Policies?
Regulatory bodies rely on comprehensive data to formulate guidelines for the safe use of nanomaterials. The absence of such data hampers the creation of effective regulatory frameworks. This not only poses risks to human health and the environment but also creates uncertainty for industries looking to invest in nanotechnology. Therefore, bridging these data gaps is crucial for both safety and economic growth.
